Literature DB >> 9126960

Disruption of T cell tolerance by directing a self antigen to macrophage-specific scavenger receptors.

R Abraham1, A Choudhury, S K Basu, V Bal, S Rath.   

Abstract

Breakdown of immune self tolerance is speculated to cause autoimmune diseases, but most studies on tolerance use foreign molecules as targets. In this study, we show another approach using delivery of a maleylated self protein to macrophage-specific scavenger receptors. Mice generate Abs against the maleylated form of a ubiquitous self Ag, mouse serum albumin (MSA), although native MSA is nonimmunogenic. This generation of anti-maleyl MSA Abs depends on binding of maleyl MSA to scavenger receptors in vivo, since coinjection of a serologically unrelated scavenger receptor ligand inhibits it, suggesting that the Ab response is T cell dependent. Spleen cells as well as nylon adherence-purified splenic T cells from maleyl MSA-immune mice proliferate in response to both maleyl MSA and MSA; this response is blocked by anti-MHC class II mAbs, and the autoimmune cells can recognize at least five 15-mer peptides from the MSA sequence, establishing that T cell tolerance to MSA has been broken in these mice. Maleyl MSA and MSA are recognized equally well, provided the scavenger receptor-specific delivery of maleyl MSA is blocked during stimulation in vitro, indicating that maleyl MSA-specific non-self peptides are unlikely to play a major role in the observed disruption of T cell tolerance. Thus, delivery of some self molecules to scavenger receptors may lead to disruption of immune tolerance. These results are relevant to mechanisms of immune tolerance and the etiopathogenesis of autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126960

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites.

Authors:  Geoffrey M Thiele; Michael J Duryee; Monte S Willis; Dean J Tuma; Stanley J Radio; Carlos D Hunter; Courtney S Schaffert; Lynell W Klassen
Journal:  Alcohol Clin Exp Res       Date:  2010-09-22       Impact factor: 3.455

Review 2.  Immunological response in alcoholic liver disease.

Authors:  Michael J Duryee; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

Review 3.  Engineering immunity: Modulating dendritic cell subsets and lymph node response to direct immune-polarization and vaccine efficacy.

Authors:  Jardin Leleux; Alexandra Atalis; Krishnendu Roy
Journal:  J Control Release       Date:  2015-10-20       Impact factor: 9.776

4.  T-cell recognition of lipid peroxidation products breaks tolerance to self proteins.

Authors:  D M Wuttge; M Bruzelius; S Stemme
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

5.  Macrophage scavenger receptor 1 (Msr1, SR-A) influences B cell autoimmunity by regulating soluble autoantigen concentration.

Authors:  Stefanie Haasken; Jennifer L Auger; Justin J Taylor; Patricia M Hobday; Brian D Goudy; Philip J Titcombe; Daniel L Mueller; Bryce A Binstadt
Journal:  J Immunol       Date:  2013-06-21       Impact factor: 5.422

6.  A microarray screen for novel candidate genes in coeliac disease pathogenesis.

Authors:  B Diosdado; M C Wapenaar; L Franke; K J Duran; M J Goerres; M Hadithi; J B A Crusius; J W R Meijer; D J Duggan; C J J Mulder; F C P Holstege; C Wijmenga
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

Review 7.  Inflammation and immune response in atherosclerosis.

Authors:  G K Hansson
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.967

8.  Nitration of the pollen allergen bet v 1.0101 enhances the presentation of bet v 1-derived peptides by HLA-DR on human dendritic cells.

Authors:  Anette C Karle; Gertie J Oostingh; Sonja Mutschlechner; Fatima Ferreira; Peter Lackner; Barbara Bohle; Gottfried F Fischer; Anne B Vogt; Albert Duschl
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.